| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |